CClinicalTrials.gg
CompletedNCT05073081Updated Nov 20, 2024

Feasibility of Prehab for Lumbar Spinal Stenosis

An interventional study of Prehab for LSS and Usual Care in Lumbar Spinal Stenosis and Prehabilitation, sponsored by McMaster University. Completed at 4 sites in Canada. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2024-11-20.

Sponsored by McMaster University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

The literature has shown evidence of the effectiveness of prehabilitation programs on post-operative recovery for musculoskeletal conditions; however, evidence for prehabilitation for lumbar spinal stenosis (LSS) is limited. Investigators have found that there is very low to low quality evidence for the effect of prehabilitation interventions for improving outcomes following lumbar spine surgery. Therefore, the purpose of this study will be to determine the feasibility of a prehabilitation program for patients undergoing LSS surgery, and pilot test the protocol to provide the foundation for future design of a larger, multicenter randomized controlled trial.

Read the detailed description

Background:

Lumbar spinal stenosis (LSS) is the most common degenerative condition among older adults, and the leading reason older adults aged 65 and older undergo surgery. LSS is characterized by degenerative changes that lead to loss of intervertebral disc spaces, joint thickening, and enfolding of the ligaments surrounding the spine. These degenerative changes may cause compression of lumbosacral nerve roots resulting in the narrowing of central and vertebral canals known as neurogenic claudication (NC). The symptoms of NC include cramping, numbness or tingling, and muscle weakness in the lower back, buttocks, or one or both legs, with symptoms often intensifying with standing and walking.

The majority of individuals undergoing surgery for LSS are post-retirement age, have chronic low back pain, without access to private rehabilitation. This population is often severely deconditioned prior to surgery with weakness and atrophy of the muscles in the back, core, and lower limb. These preoperative factors have been shown to be predictors for postoperative LSS outcomes. Studies have shown evidence of the effectiveness of prehabilitation programs on post-operative recovery for other musculoskeletal conditions such as total knee arthroplasty. However, there appears to be a lack of high-quality evidence for the effect of prehabilitation interventions in improving outcomes for LSS surgery.

Research Aims:

The purpose of this study is to determine the feasibility of the program of care on a group of patients with LSS undergoing surgery, and determine the feasibility of the protocol for a randomized controlled trial.

Methods:

This mixed methods study will include a two-armed, pilot RCT evaluating an 8-week virtual prehabilitation program for participants undergoing LSS surgery, with a longitudinal qualitative study conducted parallel to the pilot RCT. The two groups in the RCT study will be: 1) prehabilitation, and 2) usual care.

Recruitment:

There will be 60 participants recruited from participating spine surgeons in 3 Canadian cities - Hamilton, Edmonton, and Calgary. Participants will be included if 1) they are a minimum 20 weeks prior to their date of surgery, 2) older than 55 years of age, 3) are scheduled for first spine surgery , and 4) are English-speaking. Participants will be excluded if 1) they have a known or suspected pathology (e.g., cancer, cauda equina syndrome), 2) are unable to engage in exercise due to other comorbidities or cognitive issues, and 3) if they do not have access to the Internet.

Interventions:

The 8-week prehabilitation program will be delivered online using synchronous and asynchronous sessions delivered by either a physiotherapist, chiropractor or kinesiologist, with a booster session at 6-weeks post-op. There will be 4 individual exercises sessions (week 1, 2, 4 and 8) delivered synchronously using Zoom or Physitrack in which motivational interviewing and graded activity exercises will be conducted. Participants will also be asked to exercise at least 3 times a week using the asynchronous exercise videos. Participants will receive short online educational videos (3-5 minutes). Educational sessions will include information regarding the importance of exercise, pain education, self-management, exercising despite pain, post-operative expectations, and information regarding their upcoming surgery. The educational sessions will also include two online peer-support groups when they can interact with a patient with a history of LSS surgery.

Participants in the control group will receive usual care for LSS surgery, which will consist of one session with an anesthesiologist, a nurse and access to our online educational videos.

Outcomes:

Outcomes will be evaluated at: baseline (\~20 weeks before LSS surgery), immediately after the intervention (8-weeks), 3 and 12 months post-operatively. Feasibility outcomes are: 1) recruitment rate; 2) patient adherence to the program and attrition rates; 3) acceptability of program content; and 4); acceptability of study procedures and completion of study questionnaires. Patient reported outcomes will be used to inform feasibility, study burden and sample size calculations. These outcomes include: pain and disability, health-related quality of life, psychological measures, and monitoring variables. Ecological Momentary Assessments using activity monitors will be used to evaluate walking ability and daily pain.

Qualitative Methods A longitudinal qualitative study will be conducted parallel to the pilot RCT. We will use purposive sampling to conduct in-depth semi structured interviews at baseline (\~20 weeks before LSS surgery), 8-weeks after the intervention, 3 months, and 12 months post-operatively. For the qualitative study, we will aim to recruit 12-15 participants or until saturation is met. The longitudinal qualitative study will assess the barriers and facilitators that influence engagement in prehabilitation, as well as the changes in pain and health that occur over time and how these are related to the program, personal (e.g., sex and gender, age, comorbid health, pain profile) or contextual factors (psychosocial, environmental, health systems).

Analysis:

All analyses will be conducted using STATA 15. Descriptive statistics will be used to report feasibility outcomes, as well as to identify trends in patient-reported outcomes. Qualitative interviews will be analyzed using interpretive phenomenological analysis (IPA) informed by the Consolidated Criteria for Reporting Qualitative Studies. Inductive thematic analysis will be used to analyze the data and report the study findings.

02

Conditions studied

  • Lumbar Spinal Stenosis
  • Prehabilitation

Keywords

  • Prehabilitation
  • Spinal stenosis
  • Surgery
  • Exercise therapy
03

In context

Spinal Stenosis

459 studies on the registry are indexed under Spinal Stenosis; 103 are open to participants now.

This study's enrollment of 37 is below the median of 80 across 283 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Minimum 20 weeks prior to date of LSS surgery
  • Older than 55 years of age
  • Scheduled for first spinal surgery
  • Can read and understanding English, with no significant visual or hearing impairment that would require additional support

Exclusion criteria

Exclusion Criteria:

  • Known or suspected pathology (e.g., cancer, cauda equina syndrome)
  • Unable to engage in exercise due to other comorbidities
  • No access to the Internet
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    Prehabilitation

    The 8-week prehabilitation program will be delivered online using synchronous and asynchronous sessions delivered by either a physiotherapist, chiropractor or kinesiologist. There will be 4 individual exercises sessions delivered synchronously using Zoom or Physitrack in which motivational interviewing and graded activity exercises will be conducted. Participants will also be asked to exercise at least 3 times a week using the asynchronous exercise videos. The exercises will be individualized on participants functional ability and personal goals identified at baseline, with a focus on muscle strengthening, stretching, improving spinal flexibility and stability. There will be a booster session at 6-weeks post-op. Participants will also undergo 5 group educational sessions, which will provide information regarding: goal setting, pain education, self-management, pacing, post-operative expectations, exercise recommendations, and information regarding their upcoming surgery.

    Other: Prehab for LSS

  • Active comparator
    Usual Care

    Participants in the control group will receive usual care as per surgeons' current practice. This generally consists of one session with an anesthesiologist, a nurse and access to our online videos.

    Other: Usual Care

Interventions

  • OtherPrehab for LSS

    The 8-week prehabilitation program will be delivered online by physiotherapists, chiropractors, and kinesiologists through synchronous and asynchronous exercise sessions, along with online educational sessions.

  • OtherUsual Care

    Participants in the control group will receive usual care as per surgeons' current practice.

06

What researchers measure

Primary outcomes

  1. Patient Adherence

    Measured by patient diary, app-based program 1. Proceed with study if 80% of participants attended all 4 exercise sessions 2. Proceed with study if 60% of participants report exercise at last 3x/week.

    Time frame: During the 8-week Intervention

  2. Recruitment Rate

    Proceed with study if 50% of eligible participants consent to participate within 4 months

    Time frame: 20 weeks before LSS surgery

  3. Content Acceptability

    Measured using a survey administered at the end of the 8-week intervention 1. Proceed with the study if 60% found treatment useful (\>7/10 on a Likert scale) 2. Proceed with the study if 60% found treatment helpful (\>7/10 on a Likert scale)

    Time frame: Immediately after the intervention (8-weeks)

  4. Format Acceptability

    Measured using a survey administered at the end of the 8-week intervention 1. Proceed with the study if 60% found treatment delivery acceptability (\>7/10 on a Likert scale) 2. Proceed with the study if 60% of participants reported being likely to recommend this treatment (\>7/10 on a Likert scale) 3. Proceed with the study if 60% reported being likely to use this treatment again (\>7/10 on a Likert scale)

    Time frame: Immediately after the intervention (8-weeks)

  5. Follow-up

    1. Proceed with the study if 90% of participants follow-up at the end of the prehab intervention 2. Proceed with the study if 85% of participants follow-up at 6 months 3. Proceed with the study if 85% of participants follow-up at 12 months 4. Proceed with the study if 60% reported being likely to use this treatment again (\>7/10 on a Likert scale)

    Time frame: Immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  6. Burden

    Proceed with the study if 60% reported being likely to use this treatment again (\>7/10 on a Likert scale)

    Time frame: Immediately after the intervention (8-weeks)

Secondary outcomes

  1. The Oswestry Disability Index

    Disease specific questionnaire designed to evaluate pain and function in this patient population, using a numerical rating scale.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  2. Swiss Spinal Stenosis Questionnaire - Balance

    Disease specific questionnaire designed to evaluate pain and function in this patient population.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  3. SF-12

    12-Item scale to assess the impact of health on quality of life.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  4. Patient Health Questionnaire-9

    Depression scale to monitor the severity of depression; total score from 0-27 with higher scores representing severe depression.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  5. Pain Catastrophizing Scale

    13-item scale to assess the extent of catastrophic thinking due to low back pain. Total score ranging from 0-52, along with three subscale scores assessing rumination, magnification and helplessness.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  6. 6-item Chronic Disease Self-Efficacy Scale

    6-item scale to evaluate disease related self-efficacy with higher scores indicating higher self-efficacy ranging from 0-10.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  7. Tampa Scale of Kinesiophobia

    11-item scale used to evaluate kinesiophobia and associated anxiety. Scores range from 17-68 with higher scores indicating severe kinesiophobia.

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

  8. Ecological Momentary Assessment

    Total weekly minutes of physical activity (PA) will be captured with a wearable tri-axial accelerometer device (Actiwatch Spectrum Pro Startup, Philips, USA) worn for seven consecutive days. Pain and fatigue will be measured using a 10-point scale with higher scores representing worse pain and fatigue, which will be measured 3 times a day for 7 days.

    Time frame: During the 8-week Intervention

  9. EQ-5D

    Measures five dimensions of patient reported health (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).

    Time frame: 20 weeks before LSS surgery, immediately after the intervention (8-weeks), 3-, and 12-months post-operatively

07

Study locations

4 sites
  • University of Calgary
    Calgary, Alberta, Canada
  • University of Toronto
    Toronto, Ontario, Canada
  • University of Alberta
    Edmonton, Canada
  • McMaster University
    Hamilton, Canada
08

References and documents

Individual participant data

Plan to share: Yes — Data may be requested directly to the principal investigator or may be made available upon publication.

Supporting information: Study protocol, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05073081
Lead sponsor
McMaster University
Collaborators
University of Calgary, University of Alberta
Responsible party
Luciana Macedo (Assistant Professor, McMaster University) — Principal investigator
First posted
Oct 11, 2021
Start date
Dec 1, 2021
Primary completion
Sep 30, 2024
Completion
Sep 30, 2024
Last update
Nov 20, 2024

Study contacts

Luciana G Macedo, PhD
principal investigator · McMaster University
Doug Gross, PhD
principal investigator · University of Alberta
Lisa Carlesso, PhD
principal investigator · McMaster University
Kenneth Thomas, MD
principal investigator · University of Calgary

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion